Published in Expert Rev Proteomics on April 01, 2010
Serum Helicobacter pylori KatA and AhpC antibodies as novel biomarkers for gastric cancer. World J Gastroenterol (2016) 0.79
Thyroxine in goiter, Helicobacter pylori infection, and chronic gastritis. N Engl J Med (2006) 2.75
Effect of chronic hypergastrinemia on human enterochromaffin-like cells: insights from patients with sporadic gastrinomas. Gastroenterology (2002) 1.62
Occurrence and risk factors for autoimmune thyroid disease in patients with atrophic body gastritis. Am J Med (2008) 1.56
Gastric carcinoid in the absence of atrophic body gastritis and with low Ki67 index: a clinical challenge. Scand J Gastroenterol (2014) 1.38
Development of an in vitro model to investigate joint ochronosis in alkaptonuria. Rheumatology (Oxford) (2010) 1.28
Pernicious anemia: new insights from a gastroenterological point of view. World J Gastroenterol (2009) 1.22
Evaluation of anti-oxidant treatments in an in vitro model of alkaptonuric ochronosis. Rheumatology (Oxford) (2010) 1.11
Extragastric manifestations of Helicobacter pylori infection. Helicobacter (2010) 1.11
Negative Helicobacter pylori status is associated with poor prognosis in patients with gastric cancer. Cancer (2009) 1.10
Alkaptonuria is a novel human secondary amyloidogenic disease. Biochim Biophys Acta (2012) 1.09
Biochemical investigation of the effects of human platelet releasates on human articular chondrocytes. J Cell Biochem (2009) 1.09
Type I gastric carcinoids: a prospective study on endoscopic management and recurrence rate. Neuroendocrinology (2011) 1.08
Can patient characteristics predict the outcome of endoscopic evaluation of iron deficiency anemia: a multiple logistic regression analysis. Gastrointest Endosc (2004) 1.08
The eradication of Helicobacter pylori is affected by body mass index (BMI). Obes Surg (2008) 1.07
Evaluation of antioxidant drugs for the treatment of ochronotic alkaptonuria in an in vitro human cell model. J Cell Physiol (2010) 1.06
Antimicrobial activity against Helicobacter pylori strains and antioxidant properties of blackberry leaves (Rubus ulmifolius) and isolated compounds. Int J Antimicrob Agents (2009) 1.06
Proton pump inhibitor therapy and potential long-term harm. Curr Opin Endocrinol Diabetes Obes (2014) 1.06
Risk for gastric neoplasias in patients with chronic atrophic gastritis: a critical reappraisal. World J Gastroenterol (2012) 1.06
Homogentisate 1,2 dioxygenase is expressed in human osteoarticular cells: implications in alkaptonuria. J Cell Physiol (2012) 1.04
Proteomic and redox-proteomic evaluation of homogentisic acid and ascorbic acid effects on human articular chondrocytes. J Cell Biochem (2010) 1.03
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: chemotherapy in patients with neuroendocrine tumors. Neuroendocrinology (2009) 1.01
Biochemical and proteomic characterization of alkaptonuric chondrocytes. J Cell Physiol (2012) 0.99
Antioxidants inhibit SAA formation and pro-inflammatory cytokine release in a human cell model of alkaptonuria. Rheumatology (Oxford) (2013) 0.98
A proteomic study on human osteoblastic cells proliferation and differentiation. Proteomics (2006) 0.98
Research needs in allergy: an EAACI position paper, in collaboration with EFA. Clin Transl Allergy (2012) 0.97
Bronchoalveolar lavage fluid protein composition in patients with sarcoidosis and idiopathic pulmonary fibrosis: a two-dimensional electrophoretic study. Electrophoresis (2002) 0.97
Artificial neural networks in the recognition of the presence of thyroid disease in patients with atrophic body gastritis. World J Gastroenterol (2008) 0.96
Proteomic response to physiological fermentation stresses in a wild-type wine strain of Saccharomyces cerevisiae. Biochem J (2003) 0.96
Redox-proteomics of the effects of homogentisic acid in an in vitro human serum model of alkaptonuric ochronosis. J Inherit Metab Dis (2011) 0.96
Extragastric manifestations of Helicobacter pylori infection -- other Helicobacters. Helicobacter (2007) 0.95
Micronutrients (Other than iron) and Helicobacter pylori infection: a systematic review. Helicobacter (2012) 0.93
A prospective study of gastric carcinoids and enterochromaffin-like cell changes in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: identification of risk factors. J Clin Endocrinol Metab (2008) 0.93
Appropriateness of the indication for colonoscopy: is the endoscopist the 'gold standard'? J Clin Gastroenterol (2012) 0.93
Comparative proteomics and immunoproteomics of Helicobacter pylori related to different gastric pathologies. J Chromatogr B Analyt Technol Biomed Life Sci (2006) 0.92
Proteome analysis of Neisseria meningitidis serogroup A. Proteomics (2004) 0.92
Cost-effectiveness of endoscopic surveillance for gastric intestinal metaplasia. Helicobacter (2010) 0.91
Treatment of diverticular disease of the colon and prevention of acute diverticulitis: a systematic review. Dis Colon Rectum (2011) 0.91
Reassessment of intrinsic factor and parietal cell autoantibodies in atrophic gastritis with respect to cobalamin deficiency. Am J Gastroenterol (2009) 0.90
Gastric neuroendocrine tumors. Neuroendocrinology (2004) 0.89
Antiproliferative and proapoptotic activities of new pyrazolo[3,4-d]pyrimidine derivative Src kinase inhibitors in human osteosarcoma cells. FASEB J (2008) 0.88
Low prevalence of idiopathic peptic ulcer disease: an Italian endoscopic survey. Dig Liver Dis (2010) 0.88
Early manifestations of gastric autoimmunity in patients with juvenile autoimmune thyroid diseases. J Clin Endocrinol Metab (2004) 0.88
Occurrence of gastric cancer and carcinoids in atrophic gastritis during prospective long-term follow up. Scand J Gastroenterol (2015) 0.87
Role of noninvasive tests (C-urea breath test and stool antigen test) as additional tools in diagnosis of Helicobacter pylori infection in patients with atrophic body gastritis. Helicobacter (2004) 0.87
CagA and VacA are immunoblot markers of past Helicobacter pylori infection in atrophic body gastritis. Helicobacter (2007) 0.87
Identification of a novel pyrazolo[3,4-d]pyrimidine able to inhibit cell proliferation of a human osteogenic sarcoma in vitro and in a xenograft model in mice. J Med Chem (2007) 0.87
Comparative analysis of the effects of locally used herbicides and their active ingredients on a wild-type wine Saccharomyces cerevisiae strain. J Agric Food Chem (2006) 0.86
Rapid aggregation and assembly in aqueous solution of A beta (25-35) peptide. J Biosci (2009) 0.85
Long-term effects of neridronate on human osteoblastic cell cultures. Bone (2004) 0.85
Cyclic antibiotic therapy for diverticular disease: a critical reappraisal. J Gastrointestin Liver Dis (2010) 0.85
2-Hydroxypropyl-β-cyclodextrin strongly improves water solubility and anti-proliferative activity of pyrazolo[3,4-d]pyrimidines Src-Abl dual inhibitors. Eur J Med Chem (2010) 0.85
Western blotting of total lysate of Helicobacter pylori in cases of atrophic body gastritis. Clin Chem (2005) 0.84
Post-genomics of bone metabolic dysfunctions and neoplasias. Proteomics (2012) 0.84
Immonium ion scanning for the discovery of post-translational modifications and its application to histones. J Proteome Res (2008) 0.84
E-cadherin germline mutation carriers: clinical management and genetic implications. Cancer Metastasis Rev (2014) 0.84
Amyloidosis in alkaptonuria. J Inherit Metab Dis (2015) 0.84
Helicobacter pylori immunoproteomes in case reports of rosacea and chronic urticaria. Proteomics (2005) 0.83
Characterization of plasma factors that alter the permeability to albumin within isolated glomeruli. Proteomics (2002) 0.83
Two-step elution of human serum proteins from different glass-modified bioactive surfaces: a comparative proteomic analysis of adsorption patterns. Electrophoresis (2004) 0.83
Intragastric ascorbic but not uric acid is depleted in relation with the increased pH in patients with atrophic body gastritis and H. pylori gastritis. Helicobacter (2003) 0.83
Symptom patterns can distinguish diverticular disease from irritable bowel syndrome. Eur J Clin Invest (2013) 0.83
Appropriateness of the indication for colonoscopy: systematic review and meta-analysis. J Gastrointestin Liver Dis (2011) 0.82
Reversal of atrophic body gastritis after H. pylori eradication at long-term follow-up. Dig Liver Dis (2010) 0.82
Possible contribution of artificial neural networks and linear discriminant analysis in recognition of patients with suspected atrophic body gastritis. World J Gastroenterol (2005) 0.82
No higher risk for colorectal cancer in atrophic gastritis-related hypergastrinemia. Dig Liver Dis (2012) 0.82
The analysis of Neisseria meningitidis proteomes: Reference maps and their applications. Proteomics (2007) 0.82
Is proliferative colonic disease presentation changing? World J Gastroenterol (2012) 0.82
The 10th anniversary of the Junior Members and Affiliates of the European Academy of Allergy and Clinical Immunology. Pediatr Allergy Immunol (2011) 0.81
Establishment and characterization of 4 new human pancreatic cancer cell lines: evidences of different tumor phenotypes. Pancreas (2009) 0.81
Postgenomics of Neisseria meningitidis: an update. Expert Rev Proteomics (2009) 0.81
High-fibre diet and Lactobacillus paracasei B21060 in symptomatic uncomplicated diverticular disease. World J Gastroenterol (2012) 0.81
Different factors affecting human ANP amyloid aggregation and their implications in congestive heart failure. PLoS One (2011) 0.80
Proteomics and redox-proteomics of the effects of herbicides on a wild-type wine Saccharomyces cerevisiae strain. J Proteome Res (2009) 0.80
Postgenomics of Neisseria meningitidis for vaccines development. Expert Rev Proteomics (2007) 0.80
Detection of gastric precancerous conditions in daily clinical practice: a nationwide survey. Helicobacter (2014) 0.80
Linking protein oxidation to environmental pollutants: redox proteomic approaches. J Proteomics (2011) 0.79
Helicobacter pylori: immunoproteomics related to different pathologies. Expert Rev Proteomics (2007) 0.79
HLA-DRB1*03 and DRB1*04 are associated with atrophic gastritis in an Italian population. Dig Liver Dis (2010) 0.79
Chondroptosis in alkaptonuric cartilage. J Cell Physiol (2015) 0.78